Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

but Eli Lilly is in hot pursuit. The 50 mg oral semaglutide pill achieved a 15.1% weight loss in the phase 3 OASIS study involving patients who were overweight or obese, but who did not have ...

and also claim that its current Ozempic shows the greater levels of blood sugar and weight reduction when compared with Bydureon and Eli Lilly’s Trulicity. Market analysts suggest that Novo ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally.

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Like many pharma stocks, Eli Lilly (NYSE ... a weight loss candidate in pill form. And Lilly may even submit orforglipron for regulatory approval as early as this year. If Lilly is able to ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...